Chulho Park active positions
| Companies | Position | Start | End |
|---|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Chief Tech/Sci/R&D Officer | 2014-12-31 | - |
| Founder | 2014-12-31 | - |
Career history of Chulho Park
Former positions of Chulho Park
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-04-21 | 2021-06-30 |
| Mabprex, Inc. | Chief Executive Officer | 2009-12-31 | 2017-12-31 |
| Founder | 2009-12-31 | 2017-12-31 | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 2012-12-31 | 2013-08-31 |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
| Mabprex, Inc. |
- Stock Market
- Insiders
- Chulho Park
- Experience
